Instapath Inc.

HOUSTON, TX · Founded 2017 · Medtech · Private

Automated tissue processing and digital imaging platform for pathology

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
HOUSTON, TX
Founded
2017
Latest Form D
$1.8M, Sep 2019
Total capital
$3.3M
Federal grants
$1.5M
1 award · 2021
Rank in peer group#5 of 22
Private capital raised
$1.8M
1 Form D · last Sep 2019
85 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
5 pending · first 2024
Rank in peer group#5 of 22

Capital timeline

201920202021FEDERAL ↑EQUITY ↓Cumulative $3.3M$1.5M1st Form D$1.8M
201920202021FEDERAL ↑EQUITY ↓Cumulative $3.3M$1.5M1st Form D$1.8M

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II: An automated digital pathology lab for rapid on-site processing and imaging of tissue biopsies$1.5M
  • Private capital raisedForm D · SEC · 1st filing$1.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 22 peers

Line = median

Medtech · System

  • Federal grants#5 · top 23%
  • Granted patents#5 · top 23%
  • Linked publications#1 · top 5%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • David TulmanExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 7
Show all 7 patent records

Recent research by its founders

  • Small Extracellular Vesicle‐TLN1 Modulates Gastric Cancer Cells and Remodels Lymphatic Endothelial Cells Through AKT Activation to Potentiate Lymphatic Metastasis20260 cites
  • Tumor-associated mesenchymal stem/stromal cells in tumor microenvironment and carcinogenesis202514 cites
  • Exploring machine learning strategies for single-cell transcriptomic analysis in wound healing202512 cites
  • Instapath BiopticsShares a founder: Mei Wang
  • SENTIOMED, INC.Similar federal contract value in Medtech · null in contracts
  • RAPID FORENSIC CELL TYPING, INC.Similar federal contract value in Medtech · null in contracts
  • QUANTWORKS, INC.Similar federal contract value in Medtech · null in contracts
  • ESCULON LLCSimilar federal contract value in Medtech · null in contracts
  • Birkeland Current LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .